1990
DOI: 10.1038/bjc.1990.144
|View full text |Cite
|
Sign up to set email alerts
|

Nucleolar organiser regions in myeloma and benign paraproteinaemia

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

1992
1992
2000
2000

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 1 publication
0
1
0
Order By: Relevance
“…18 19 The AgNOR count has also been found to correlate well with plasma cell proliferative activity, measured by bromodeoxyuridine or proliferating cell nuclear antigen expression. 20 21 However, another study did not show any diVerence in AgNOR count between multiple myeloma and monoclonal gammopathy of undetermined importance, 22 although it is known that the mitotic potential of the plasma cells is one of the most reliable diVerentiating features of the two conditions. 23 Our data do not allow us to draw conclusions on the association between AgNOR count and proliferative activity in multiple myeloma, but we did not find a clear prognostic value for AgNOR enumeration in our study population.…”
Section: Discussionmentioning
confidence: 98%
“…18 19 The AgNOR count has also been found to correlate well with plasma cell proliferative activity, measured by bromodeoxyuridine or proliferating cell nuclear antigen expression. 20 21 However, another study did not show any diVerence in AgNOR count between multiple myeloma and monoclonal gammopathy of undetermined importance, 22 although it is known that the mitotic potential of the plasma cells is one of the most reliable diVerentiating features of the two conditions. 23 Our data do not allow us to draw conclusions on the association between AgNOR count and proliferative activity in multiple myeloma, but we did not find a clear prognostic value for AgNOR enumeration in our study population.…”
Section: Discussionmentioning
confidence: 98%